Accéder au contenu
Merck

Principles of signaling pathway modulation for enhancing human naive pluripotency induction.

Cell stem cell (2021-04-30)
Jonathan Bayerl, Muneef Ayyash, Tom Shani, Yair Shlomo Manor, Ohad Gafni, Rada Massarwa, Yael Kalma, Alejandro Aguilera-Castrejon, Mirie Zerbib, Hadar Amir, Daoud Sheban, Shay Geula, Nofar Mor, Leehee Weinberger, Segev Naveh Tassa, Vladislav Krupalnik, Bernardo Oldak, Nir Livnat, Shadi Tarazi, Shadi Tawil, Emilie Wildschutz, Shahd Ashouokhi, Lior Lasman, Varda Rotter, Suhair Hanna, Dalit Ben-Yosef, Noa Novershtern, Sergey Viukov, Jacob H Hanna
RÉSUMÉ

Isolating human MEK/ERK signaling-independent pluripotent stem cells (PSCs) with naive pluripotency characteristics while maintaining differentiation competence and (epi)genetic integrity remains challenging. Here, we engineer reporter systems that allow the screening for defined conditions that induce molecular and functional features of human naive pluripotency. Synergistic inhibition of WNT/β-CATENIN, protein kinase C (PKC), and SRC signaling consolidates the induction of teratoma-competent naive human PSCs, with the capacity to differentiate into trophoblast stem cells (TSCs) and extraembryonic naive endodermal (nEND) cells in vitro. Divergent signaling and transcriptional requirements for boosting naive pluripotency were found between mouse and human. P53 depletion in naive hPSCs increased their contribution to mouse-human cross-species chimeric embryos upon priming and differentiation. Finally, MEK/ERK inhibition can be substituted with the inhibition of NOTCH/RBPj, which induces alternative naive-like hPSCs with a diminished risk for deleterious global DNA hypomethylation. Our findings set a framework for defining the signaling foundations of human naive pluripotency.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cocktail d'inhibiteurs de protéases, for use with mammalian cell and tissue extracts, DMSO solution
Roche
Cocktail d'inhibiteurs de protéases sans EDTA Mini cOmplete, Tablets provided in EASYpacks
Sigma-Aldrich
Doxycycline hyclate
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Acide L-ascorbique 2-phosphate sesquimagnesium salt hydrate, ≥95%
Sigma-Aldrich
Collagène from human placenta, Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Milieu de Eagle modifié par Dulbecco (DMEM)/Mélange nutritif F-12 de Ham, With 15 mM HEPES and sodium bicarbonate, without L-glutamine, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Valproic acid sodium salt, 98%
Sigma-Aldrich
Putrescine dihydrochloride, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Sodium selenite, BioReagent, suitable for cell culture, ≥98%
Sigma-Aldrich
Progesterone, powder, BioReagent, suitable for cell culture
Roche
RNase, DNase-free, from bovine pancreas
Sigma-Aldrich
Dimethyl 2-oxoglutarate, 96%
Sigma-Aldrich
Anticorps anti-noyau, clone 235-1, clone 235-1, Chemicon®, from mouse
Sigma-Aldrich
XAV939, ≥98% (HPLC)
Sigma-Aldrich
bisBenzimide H 33342 trihydrochloride, ≥98% (HPLC and TLC)
Sigma-Aldrich
Anti-KLF17 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
SGC0946, ≥98% (HPLC)
Sigma-Aldrich
Kenpaullone, A potent, cell-permeable, and reversible inhibitor of glycogen synthase kinase-3β (IC₅₀ = 230 nM), Lck (IC₅₀ = 470 nM), and cyclin-dependent kinases (Cdks).